Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment
Open Access
- 31 May 2018
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 68, 69-79
- https://doi.org/10.1016/j.ctrv.2018.05.015
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- High endothelial venules (HEVs) in human melanoma lesionsOncoImmunology, 2012
- Characterization of the inflammatory response to solid cancer metastases in the human brainClinical & Experimental Metastasis, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain MetastasesJournal of Clinical Oncology, 2012
- Integrin β4 Signaling Promotes Mammary Tumor Cell Adhesion to Brain Microvascular Endothelium by Inducing ErbB2-Mediated Secretion of VEGFAnnals of Biomedical Engineering, 2011
- Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasisClinical & Experimental Metastasis, 2010
- HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary TumorsClinical Cancer Research, 2009
- Activation of tumor cell integrin α v β 3 controls angiogenesis and metastatic growth in the brainProceedings of the National Academy of Sciences of the United States of America, 2009
- Long-term survival in patients with brain metastasesZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology*Biology*Physics, 1997